A microfluidic chip for fluorescent immunoassay and its preparation method
A technology of microfluidic chips and fluorescent immunity, applied in the field of medical testing, can solve the problems of large batches, no quality control area, intra-batch variation, etc., to improve product quality, reduce product batch and/or intra-batch variation , the effect of good detection sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0056] The preparation method of the phosphate buffer is: dissolving sodium dihydrogen phosphate and disodium hydrogen phosphate in water;
[0057] The preparation method of described citric acid-sodium citrate buffer solution is: trisodium citrate, citric acid and sodium hydroxide are dissolved in water;
[0058] The preparation method of the blocking solution is as follows: bovine serum albumin, sucrose, sodium dihydrogen phosphate, disodium hydrogen phosphate and Proclin300 are dissolved in water.
[0059] Detection principle:
[0060] As shown in the figure, driven by centrifugal force, the whole blood sample passes through the filter zone to remove blood cells, and then passes through the antibody coating zone;
[0061] Use the water in the sample to dry the biotin-labeled biotin-labeled with the analyte antibody, fluorescent microspheres labeled with the analyte antibody, fluorescent microspheres labeled quality control antibody, and then the mixture moves together to ...
Embodiment 1
[0067] In the following, the present invention will be described by taking a microfluidic chip for detecting cardiac troponin I (cTnI) as an example:
[0068] 1. Treatment of whole blood filtration area
[0069] Cut the red blood cell filter membrane into corresponding specifications, and stick it on the whole blood filter area with an instrument.
[0070] 2. Treatment of antibody-coated area
[0071] 2.1 Biotin-labeled mouse anti-cTnI monoclonal antibody
[0072] First, dilute the biotin-labeled mouse anti-cTnI monoclonal antibody to 1 mg / mL with sodium carbonate buffer, and dialyze with sodium carbonate buffer at room temperature (25°C±5°C) for 4 hours in the dark; 6-Aminocaproic acid-N-hydroxysuccinimide-biotin (BCNHS) was prepared in methylamide (DMF) to 1 mg / mL; add 125 μL of the above DMF solution to 1 mL of mouse anti-cTnI monoclonal antibody solution for biotin labeling Mix in a glass bottle, stir at room temperature (25°C±5°C) in the dark for 2 hours; add 9.6 μL of...
Embodiment 2
[0133] The microfluidic chip for detecting cardiac troponin I (cTnI) in this example is similar to that in Example 1, the only difference is the biotin-labeled analyte antibody in the antibody-coated area and the analyte labeled with fluorescent microspheres The molar ratio of antibody and fluorescent microsphere-labeled quality control antigen = 4:1:1.
[0134] Using the microfluidic chip of the present embodiment, the detected data shows that the corresponding data of T / C and cardiac troponin I concentration are as follows:
[0135] Table II:
[0136] Cardiac troponin I concentration
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com